Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Prussick

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Seminars in Cutaneous Medicine and Surgery|December 1, 1996
Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapyR Prussick
Journal of the American Academy of Dermatology|August 1, 1996
Dapsone hypersensitivity syndromeR Prussick, N H Shear
Archives of Dermatology|May 1, 1993
Recall of cutaneous toxicity from fluorouracilR Prussick, A Thibault, M L Turner
Archives of Dermatology|July 1, 1994
Recurrence of pemphigus vulgaris associated with interleukin 2 therapyR Prussick, R T Plott, J R Stanley
Dermatology (Basel, Switzerland)|January 1, 1994
Pemphigus vulgaris antigen is a desmosomal desmogleinS Kárpáti, M Amagai, R Prussick, et al.
Archives of Dermatology|February 1, 1992
The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformisR Prussick, M A Ali, D Rosenthal, et al.
The Journal of Cell Biology|July 1, 1993
Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomesS Kárpáti, M Amagai, R Prussick, et al.
Journal of the American Academy of Dermatology|September 1, 1991
Polymyositis: a manifestation of chronic graft-versus-host diseaseR Prussick, M C Brain, I R Walker, et al.
Journal of the American Academy of Dermatology|April 1, 1991
Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinaseA Patel, R Prussick, W W Buchanan, et al.
Journal of the American Academy of Dermatology|November 1, 1996
A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1 alphaR Prussick, T D Horn, W H Wilson, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Seminars in Cutaneous Medicine and Surgery|December 1, 1996
Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapyR Prussick
Journal of the American Academy of Dermatology|August 1, 1996
Dapsone hypersensitivity syndromeR Prussick, N H Shear
Archives of Dermatology|May 1, 1993
Recall of cutaneous toxicity from fluorouracilR Prussick, A Thibault, M L Turner
Archives of Dermatology|July 1, 1994
Recurrence of pemphigus vulgaris associated with interleukin 2 therapyR Prussick, R T Plott, J R Stanley
Dermatology (Basel, Switzerland)|January 1, 1994
Pemphigus vulgaris antigen is a desmosomal desmogleinS Kárpáti, M Amagai, R Prussick, et al.
Archives of Dermatology|February 1, 1992
The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformisR Prussick, M A Ali, D Rosenthal, et al.
The Journal of Cell Biology|July 1, 1993
Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomesS Kárpáti, M Amagai, R Prussick, et al.
Journal of the American Academy of Dermatology|September 1, 1991
Polymyositis: a manifestation of chronic graft-versus-host diseaseR Prussick, M C Brain, I R Walker, et al.
Journal of the American Academy of Dermatology|April 1, 1991
Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinaseA Patel, R Prussick, W W Buchanan, et al.
Journal of the American Academy of Dermatology|November 1, 1996
A characteristic eruption associated with ifosfamide, carboplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1 alphaR Prussick, T D Horn, W H Wilson, et al.
Pageof 2